Molecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyr

Diagn Microbiol Infect Dis. 2010 Jan;66(1):116-9. doi: 10.1016/j.diagmicrobio.2009.06.007. Epub 2009 Aug 25.

Abstract

Candida kefyr has been increasingly associated with bloodstream infections. This study reports on the identification and antifungal susceptibility pattern of 33 Candida isolates, identified biochemically as C. kefyr. One strain was finally identified as Candida sphaerica (Kluyveromyces lactis) by ITS sequencing. Both species seem to be emerging pathogens and highly susceptible in vitro to currently licensed antifungal compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Candida / drug effects*
  • Candida / genetics*
  • Candida / pathogenicity
  • Candidiasis / microbiology
  • DNA, Intergenic / genetics
  • Fungemia / microbiology
  • Genes, Fungal / genetics
  • Humans
  • Kluyveromyces / drug effects
  • Kluyveromyces / genetics
  • Kluyveromyces / physiology
  • Microbial Sensitivity Tests
  • Sequence Analysis, DNA / methods*

Substances

  • Antifungal Agents
  • DNA, Intergenic